ArticleRevista medica del Instituto Mexicano del Seguro Social2022
[Quality of care in patients with prostate cancer treated in Mexico].
Article in Revista medica del Instituto Mexicano del Seguro Social, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- [Efficiency and safety of transperineal prostate biopsy with a single access point].Revista medica del Instituto Mexicano del Seguro Social · 2026Observational
- Development and Validation of a Predictive Model of Prostate Screening Compliance: A Nationwide Population-Based Study.The Prostate · 2025Observational
- [ROC curves: general characteristics and their usefulness in clinical practice].Revista medica del Instituto Mexicano del Seguro Social · 2023Article
- [Evaluation of the quality of anesthetic recovery in postoperative patients].Revista medica del Instituto Mexicano del Seguro Social · 2023Observational
- Understanding Drivers of Prostate Cancer Screening in Mexican-Origin Men Along the U.S./Mexico Border Region.American journal of men's healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patient-centered care model improves quality of care, decreases unnecessary use of services, optimizes costs and quality of life and survival for cancer patients. Objective: To compare the patient-centered quality of care of prostate cancer patients with and without social security in two oncology hospitals in Mexico City. Material and methods: The information of the 2019 survey of prostate cancer patients in two oncology hospitals, one from the Mexican Institute of Social Security (IMSS) and the other from the Ministry of Health (SSA), was analyzed (n = 307). The survey included sociodemographic and patient-centered quality of care variables. A descriptive and bivariate analysis was performed to compare the quality of care between both hospitals using chi-square test, Fisher's exact test and Student's t test. Results: 234 patients treated at the IMSS and 73 at the SSA were included, with a mean age of 66.6 years. In both hospitals, more than 90% of the patients perceived respectful and coordinated care, as well as clear information. Only 58.9% of patients treated at SSA received information for decision-making, in contrast to 80.8% at IMSS (p = 0.001). Supportive care for biopsychosocial needs was low in both places (IMSS: 23.9%, SSA: 13.7%, p = 0.063). Conclusions: The quality of care focused on patients with prostate cancer was perceived as good, except in the care of biopsychosocial needs; given the importance of this last aspect, it is recommended a multidisciplinary approach in their care.
Indexed as
Identifiers
35759755PMC10395871What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.